Home

Kevin Robert Lind

CIK 1677036 · President and CEO · last filed 2026-07-02

Kevin Robert Lind is a President and CEO who has filed 19 SEC Form 4 insider transactions across 3 companies since 2016. The most recent filing, for AVTX, was dated Jul 2, 2026. Across all open-market trades the lifetime net is −$247.5K, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

19

Lifetime Open-Market Net

-$247.5K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AVTX Director — $19.52 — $0 5 2026-07-02
Longboard Pharmaceuticals, Inc. (LBPH) Delisted President and CEO 0 $59.98 $0 $0 7 2024-12-02
ARENA PHARMACEUTICALS INC (ARNA) Delisted Executive VP and CFO 7,957 $99.99 $795.6K -$247.5K 7 2020-03-03

Recent Filings

19 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-02 AVTX Grant (A) — $0 EDGAR
2026-06-04 AVTX Grant (A) — $0 EDGAR
2026-04-01 AVTX Grant (A) — $0 EDGAR
2026-01-05 AVTX Grant (A) — $0 EDGAR
2025-10-02 AVTX Grant (A) — $0 EDGAR
2024-12-02 Longboard Pharmaceuticals, Inc. (LBPH) Delisted Mixed −363,740 -$21.82M EDGAR
2024-11-13 Longboard Pharmaceuticals, Inc. (LBPH) Delisted Mixed −67,192 $40.0K EDGAR
2024-10-29 Longboard Pharmaceuticals, Inc. (LBPH) Delisted Grant (A) — $0 EDGAR
2024-08-13 Longboard Pharmaceuticals, Inc. (LBPH) Delisted Exer (M) +82,482 $260.0K EDGAR
2024-02-09 Longboard Pharmaceuticals, Inc. (LBPH) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 19
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.